N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Memory Support System Feasibility Study

Sponsor: Bruyère Health Research Institute. • ClinicalTrials.gov ID: NCT05999929

Registry updated: 2026-09-25
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

The purpose of this study is to determining the feasibility of providing the Memory Support System (MSS) to individuals with mild cognitive impairment (MCI) and their partners at a clinic in Ontario, Canada. This will involve a) collecting information from patients referred to the a memory clinic and geriatric day hospital about the patient's interest in and the patient's preferred method to administer the MSS; and b) a cost analysis related to implementation of the MSS. The study will also measure efficacy outcomes of the MSS regarding program adherence as well as to self-reported IADLs, self-efficacy for memory, quality of life, mood, anxiety, and caregiver burden among a sample of individuals with MCI and their care partners

Interventions

  • Memory Support System (Behavioral)
    The MSS is a two-page-per-day, pocket-sized calendar/note-taking system with three sections: (a) events; (b) to do's; and (c) journaling for logging important things to be remembered (e.g., news about family/friends). MSS training consists of ten 1-hour sessions delivered over two or six weeks, starting 7-10 days after baseline assessment.

Eligibility criteria

Inclusion Criteria: * diagnosis of single or multi-domain MCI * Clinical Dementia Rating global (CDR) score of ≤ 0.5 * Montreal Cognitive Assessment score of ≥18 * available contact with a care partner ≥ 2 times weekly * absence or stable intake of nootropic(s) for ≥ 3 months Exclusion Criteria: * visual/hearing impairment and/or history of reading or written inability/disability sufficient to interfere with MSS training * concurrent participation in another related clinical trial

Conditions

Mild Cognitive Impairment

Locations

  • Bruyère Health Research Institute — Ottawa, Ontario, Canada
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record